Single-point accountability from verified factory audits and proforma negotiation to 100% Bilateral Escrow, on-site QA inspection, cold-chain shipment, and customs clearance.
Funds locked in neutral institutional custody; released only upon verified buyer POD and batch inspection signoff.
On-site geo-tagged physical audits, cleanroom pressure logging, and active ISO 13485 / WHO-GMP accreditation checks.
Container & batch HPLC assay purity verification by certified Eximov Trade Engineers before factory gate release.
Reefer containers, real-time IoT temperature telemetry (+2°C to +8°C), and automated EU ICS2 customs pre-filing.
How global healthcare buyers and verified Indian manufacturers execute high-value cross-border transactions under structured bilateral compliance.
RFQ structuring, target pricing, and formal Purchase Order issuance.
Buyer defines target active ingredients, medical device specifications, IncoTerms (FOB/CIF/DDP), and required volume tiers.
How our single point of accountability eliminates the risks, delays, and payment fraud inherent in open broker directories.
Lead generation & unverified messaging platforms
Direct manufacturer contracting under single-point accountability
Submit your sourcing parameters, pharmacopeia standards, and volume requirements. An Eximov Senior Trade Officer will draft a structured execution plan and formal proforma agreement within 24 hours.
Primary factory quotes from audited Indian production facilities.
Full financial protection locked under international trade escrow.
On-site sampling, HPLC purity assays, and COA validation included.
Engage directly with Eximov trade specialists to vet manufacturers, negotiate proformas, and structure a fully protected trade execution contract.